Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estramustine depolymerizes microtubules by binding to tubulin

B Dahllöf1, A Billström, F Cabral

  • 1Kabi Pharmacia Oncology, Lund, Sweden.

Cancer Research
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

Initial clinical experience with a powered circular stapler for colorectal anastomosis.

Techniques in coloproctology·2020
Same author

Use of pulp mill inorganic wastes as alternative liming materials.

Bioresource technology·2008
Same author

Short-term effects on soil properties and wheat production from secondary paper sludge application on two Mediterranean agricultural soils.

Bioresource technology·2007
Same author

Evaluation of a compost obtained from forestry wastes and solid phase of pig slurry as a substrate for seedlings production.

Bioresource technology·2006
Same author

Study of biochemical and microbiological parameters during composting of pine and eucalyptus bark.

Bioresource technology·2006
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Estramustine, an antineoplastic drug, causes cell death by depolymerizing microtubules. This study shows estramustine directly interacts with tubulin, leading to microtubule breakdown and cancer cell death.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Oncology

Background:

  • Estramustine is an antineoplastic drug used in prostate cancer treatment.
  • Its precise mechanism of action, particularly its interaction with microtubules, requires further elucidation.
  • Previous studies suggested potential interaction with microtubule-associated proteins (MAPs).

Purpose of the Study:

  • To investigate the mechanism of action of estramustine in human prostate cancer cells.
  • To determine whether estramustine interacts with tubulin or MAPs to cause microtubule depolymerization.
  • To clarify the direct molecular target of estramustine.

Main Methods:

  • Comparison of estramustine and vinblastine effects on prostate cancer cells.
  • Assessment of mitotic arrest and microtubule depolymerization.

Related Experiment Videos

  • Utilizing cell lines with tubulin mutations (colcemid-resistant/hypersensitive).
  • In vitro studies on MAPs binding to microtubules and purified tubulin polymerization.

    • Main Results:

    • Both estramustine and vinblastine induced mitotic arrest and microtubule depolymerization.
    • Cell lines with tubulin mutations showed collateral cross-resistance or sensitivity to estramustine.
    • Estramustine did not affect MAPs binding to microtubules in vivo.
    • Estramustine directly inhibited the polymerization of purified tubulin in vitro.

    Conclusions:

    • Estramustine's cytotoxicity stems from its microtubule depolymerization properties.
    • The drug directly interacts with tubulin, not MAPs, to disrupt microtubule dynamics.
    • This direct interaction with tubulin is the primary mechanism of estramustine's anti-cancer effect.